SPECTRUM PHARMACEUTICALS INC·4

May 17, 6:38 PM ET

SHROTRIYA RAJESH C MD 4

4 · SPECTRUM PHARMACEUTICALS INC · Filed May 17, 2018

Insider Transaction Report

Form 4
Period: 2018-05-17
SHROTRIYA RAJESH C MD
DirectorChairman, CEO & President
Transactions
  • Gift

    Common Stock, $0.001 par value

    2018-05-17+362,926978,889 total(indirect: By Trust)
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2018-05-17$1.43/sh+112,500$160,875313,152 total
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2018-05-17$1.47/sh+250,426$368,126563,578 total
  • Exercise/Conversion

    Stock Option Exercise (Right to Buy)

    2018-05-17250,4260 total
    Exercise: $1.47From: 2012-01-16Exp: 2019-01-16Common Stock (250,426 underlying)
  • Gift

    Common Stock, $0.001 par value

    2018-05-17362,926200,652 total
  • Exercise/Conversion

    Stock Option Exercise (Right to Buy)

    2018-05-17112,5000 total
    Exercise: $1.43From: 2011-12-06Exp: 2018-12-06Common Stock (112,500 underlying)
Holdings
  • Common Stock, $0.001 par value

    (indirect: By Spouse)
    9,523
  • Common Stock, $0.001 par value

    (indirect: By Foundation)
    67,144
  • Common Stock, $0.001 par value

    (indirect: By Trust)
    1,787,542
  • Common Stock, $0.001 par value

    (indirect: By 401(k))
    28,907
  • Common Stock, $0.001 par value

    (indirect: By IRA)
    40,000
  • Common Stock, $0.001 par value

    (indirect: By Trust)
    1,243,284
Footnotes (1)
  • [F1]Transfer for estate planning purposes by Reporting Person to the CS Family Trust. The Reporting Person has an indirect beneficial ownership as trustee of the CS Family Trust.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION